158 related articles for article (PubMed ID: 28594406)
1. Simvastatin treatment boosts benefits of apoptotic cell infusion in murine lung fibrosis.
Lee YJ; Kim MJ; Yoon YS; Choi YH; Kim HS; Kang JL
Cell Death Dis; 2017 Jun; 8(6):e2860. PubMed ID: 28594406
[TBL] [Abstract][Full Text] [Related]
2. A STAT6 Inhibitor AS1517499 Reduces Preventive Effects of Apoptotic Cell Instillation on Bleomycin-Induced Lung Fibrosis by Suppressing PPARγ.
Kim MJ; Lee YJ; Yoon YS; Lim JH; Park EM; Chong YH; Kang JL
Cell Physiol Biochem; 2018; 45(5):1863-1877. PubMed ID: 29510393
[TBL] [Abstract][Full Text] [Related]
3. A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis.
Romero F; Shah D; Duong M; Penn RB; Fessler MB; Madenspacher J; Stafstrom W; Kavuru M; Lu B; Kallen CB; Walsh K; Summer R
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):74-86. PubMed ID: 25409201
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase inhibitor restores surfactant protein-C expression in alveolar-epithelial type II cells and attenuates bleomycin-induced pulmonary fibrosis in vivo.
Ota C; Yamada M; Fujino N; Motohashi H; Tando Y; Takei Y; Suzuki T; Takahashi T; Kamata S; Makiguchi T; Yamaya M; Kubo H
Exp Lung Res; 2015; 41(8):422-34. PubMed ID: 26151196
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic cell instillation after bleomycin attenuates lung injury through hepatocyte growth factor induction.
Lee YJ; Moon C; Lee SH; Park HJ; Seoh JY; Cho MS; Kang JL
Eur Respir J; 2012 Aug; 40(2):424-35. PubMed ID: 22441736
[TBL] [Abstract][Full Text] [Related]
7. Efferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis.
Kim KK; Dotson MR; Agarwal M; Yang J; Bradley PB; Subbotina N; Osterholzer JJ; Sisson TH
Cell Death Dis; 2018 Oct; 9(11):1056. PubMed ID: 30333529
[TBL] [Abstract][Full Text] [Related]
8. Protease-activated receptors (PAR)-1 and -3 drive epithelial-mesenchymal transition of alveolar epithelial cells - potential role in lung fibrosis.
Wygrecka M; Didiasova M; Berscheid S; Piskulak K; Taborski B; Zakrzewicz D; Kwapiszewska G; Preissner KT; Markart P
Thromb Haemost; 2013 Aug; 110(2):295-307. PubMed ID: 23739922
[TBL] [Abstract][Full Text] [Related]
9. β-catenin induces A549 alveolar epithelial cell mesenchymal transition during pulmonary fibrosis.
Song P; Zheng JX; Xu J; Liu JZ; Wu LY; Liu C
Mol Med Rep; 2015 Apr; 11(4):2703-10. PubMed ID: 25435076
[TBL] [Abstract][Full Text] [Related]
10. PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.
Yoon YS; Kim SY; Kim MJ; Lim JH; Cho MS; Kang JL
Mucosal Immunol; 2015 Sep; 8(5):1031-46. PubMed ID: 25586556
[TBL] [Abstract][Full Text] [Related]
11. [Apoptosis of type II alveolar epithelial cell induced by bleomycin in lung fibrotic rat].
Kong L; Gao YQ; Wang JF; Niu JZ; Zhang XX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):782-6. PubMed ID: 18595259
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
13. Macrophages programmed by apoptotic cells inhibit epithelial-mesenchymal transition in lung alveolar epithelial cells via PGE2, PGD2, and HGF.
Yoon YS; Lee YJ; Choi YH; Park YM; Kang JL
Sci Rep; 2016 Feb; 6():20992. PubMed ID: 26875548
[TBL] [Abstract][Full Text] [Related]
14. Reticulocalbin 3 Deficiency in Alveolar Epithelium Exacerbated Bleomycin-induced Pulmonary Fibrosis.
Jin J; Shi X; Li Y; Zhang Q; Guo Y; Li C; Tan P; Fang Q; Ma Y; Ma RZ
Am J Respir Cell Mol Biol; 2018 Sep; 59(3):320-333. PubMed ID: 29676583
[TBL] [Abstract][Full Text] [Related]
15. Paired immunoglobulin-like receptor-B inhibits pulmonary fibrosis by suppressing profibrogenic properties of alveolar macrophages.
Karo-Atar D; Moshkovits I; Eickelberg O; Königshoff M; Munitz A
Am J Respir Cell Mol Biol; 2013 Apr; 48(4):456-64. PubMed ID: 23258232
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophic tyrosine kinase receptor B/neurotrophin 4 signaling axis is perturbed in clinical and experimental pulmonary fibrosis.
Avcuoglu S; Wygrecka M; Marsh LM; Günther A; Seeger W; Weissmann N; Fink L; Morty RE; Kwapiszewska G
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):768-80. PubMed ID: 21330466
[TBL] [Abstract][Full Text] [Related]
17. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-Induced Epithelial-Mesenchymal Transition Is Involved in Bleomycin-Induced Lung Fibrosis.
Guo L; Xu JM; Liu L; Liu SM; Zhu R
Biomed Res Int; 2015; 2015():232791. PubMed ID: 26819949
[TBL] [Abstract][Full Text] [Related]
19. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis.
Vyalov SL; Gabbiani G; Kapanci Y
Am J Pathol; 1993 Dec; 143(6):1754-65. PubMed ID: 7504890
[TBL] [Abstract][Full Text] [Related]
20. Alveolar type II cell transplantation restores pulmonary surfactant protein levels in lung fibrosis.
Guillamat-Prats R; Gay-Jordi G; Xaubet A; Peinado VI; Serrano-Mollar A
J Heart Lung Transplant; 2014 Jul; 33(7):758-65. PubMed ID: 25023067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
